T. Jeffrey Elliott's Insider Trades & SAST Disclosures
T. Jeffrey Elliott's most recent trade in Quanterix Corp was a trade of 15,821 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern T. Jeffrey Elliott.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quanterix Corp | Jeffrey T. Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 15,821 | 15,821 | - | - | Stock Option (Right to Buy) | |
| Quanterix Corp | Jeffrey T. Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,435 | 19,420 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Jeffrey T. Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 25,908 | 25,908 | - | - | Stock Option (right to buy) | |
| Quanterix Corp | Jeffrey T. Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 11,985 | 11,985 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 30.02 per share. | 30 Apr 2024 | 707 | 11,931 (0%) | 0% | 30.0 | 21,224 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 291 | 11,224 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.15 per share. | 30 Apr 2024 | 136 | 11,795 (0%) | 0% | 60.1 | 8,180 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 5,291 | 15,876 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 5,291 | 13,345 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.32 per share. | 29 Feb 2024 | 2,412 | 10,933 (0%) | 0% | 59.3 | 143,080 | Common Stock |
| Exact Sciences Corp. | T. Elliott Jeffrey | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 5,701 | 10,764 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Elliott Jeffrey T. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 5,701 | 11,401 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | T. Jeffrey Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 4,750 | 4,750 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | T. Jeffrey Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 56.89 per share. | 26 Feb 2024 | 2,710 | 8,054 (0%) | 0% | 56.9 | 154,172 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 2,711 | 6,414 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | T. Jeffrey Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.78 per share. | 21 Feb 2024 | 1,351 | 5,063 (0%) | 0% | 59.8 | 80,763 | Common Stock |
| Exact Sciences Corp. | T. Elliott Jeffrey | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 3,112 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | T. Jeffrey Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 3,112 | 5,196 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | T. Jeffrey Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.50 per share. | 20 Feb 2024 | 1,493 | 3,703 (0%) | 0% | 61.5 | 91,820 | Common Stock |
| Exact Sciences Corp. | T. Jeffrey Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 3,972 | 3,972 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Elliott T. Jeffrey | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 3,972 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Elliott T. Jeffrey | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.43 per share. | 14 Feb 2024 | 1,888 | 2,084 (0%) | 0% | 61.4 | 115,980 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 82.92 per share. | 21 Aug 2023 | 30,210 | 0 (0%) | 0% | 82.9 | 2,505,013 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 30.02 per share. | 21 Aug 2023 | 709 | 30,210 (0%) | 0% | 30.0 | 21,284 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 47.41 per share. | 21 Aug 2023 | 260 | 29,501 (0%) | 0% | 47.4 | 12,327 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 5,700 | 17,102 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 5,700 | 30,037 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.12 per share. | 27 Feb 2023 | 4,233 | 29,241 (0%) | 0% | 61.1 | 258,721 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 3,437 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 3,437 | 33,474 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 21,167 | 21,167 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 3,112 | 6,225 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 3,112 | 25,767 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 62.72 per share. | 21 Feb 2023 | 1,430 | 24,337 (0%) | 0% | 62.7 | 89,690 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2023 | 3,972 | 24,521 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2023 | 3,972 | 3,972 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.59 per share. | 14 Feb 2023 | 1,866 | 22,655 (0%) | 0% | 65.6 | 122,391 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 2,579 | 21,707 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 2,579 | 0 | - | - | Performance Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 64.55 per share. | 10 Feb 2023 | 1,158 | 20,549 (0%) | 0% | 64.6 | 74,749 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 5,025 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 5,025 | 19,741 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 76.69 per share. | 28 Feb 2022 | 4,050 | 19,128 (0%) | 0% | 76.7 | 310,595 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 3,437 | 3,436 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 3,437 | 23,178 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 22,802 | 22,802 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 3,112 | 9,337 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 3,112 | 9,423 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 69.05 per share. | 22 Feb 2022 | 1,557 | 7,866 (0%) | 0% | 69.1 | 107,511 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.33 per share. | 14 Feb 2022 | 3,972 | 8,150 (0%) | 0% | 78.3 | 311,127 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 3,972 | 7,944 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.55 per share. | 14 Feb 2022 | 1,839 | 6,311 (0%) | 0% | 79.5 | 146,292 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,972 | 4,178 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 111.58 per share. | 29 Jul 2021 | 13,853 | 12,028 (0%) | 0% | 111.6 | 1,545,707 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 112.39 per share. | 29 Jul 2021 | 8,675 | 3,353 (0%) | 0% | 112.4 | 974,962 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 110.64 per share. | 29 Jul 2021 | 7,818 | 25,881 (0%) | 0% | 110.6 | 864,959 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 109.58 per share. | 29 Jul 2021 | 2,602 | 33,699 (0%) | 0% | 109.6 | 285,117 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 113.35 per share. | 29 Jul 2021 | 1,899 | 1,454 (0%) | 0% | 113.4 | 215,258 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 114.41 per share. | 29 Jul 2021 | 1,248 | 206 (0%) | 0% | 114.4 | 142,779 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 107.54 per share. | 29 Jul 2021 | 1,200 | 37,367 (0%) | 0% | 107.5 | 129,049 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 108.54 per share. | 29 Jul 2021 | 1,066 | 36,301 (0%) | 0% | 108.5 | 115,699 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 103.22 per share. | 29 Jul 2021 | 206 | 38,567 (0%) | 0% | 103.2 | 21,263 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 135.02 per share. | 03 Mar 2021 | 2,632 | 38,361 (0%) | 0% | 135.0 | 355,373 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 5,025 | 5,025 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 5,025 | 45,223 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 138.42 per share. | 01 Mar 2021 | 2,393 | 42,830 (0%) | 0% | 138.4 | 331,239 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 140.31 per share. | 01 Mar 2021 | 1,837 | 40,993 (0%) | 0% | 140.3 | 257,749 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 136.79 per share. | 26 Feb 2021 | 6,803 | 40,198 (0%) | 0% | 136.8 | 930,582 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 3,437 | 6,874 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 3,437 | 48,601 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 137.44 per share. | 26 Feb 2021 | 1,600 | 47,001 (0%) | 0% | 137.4 | 219,904 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 9,300 | 49,613 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 9,300 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 136.30 per share. | 23 Feb 2021 | 4,449 | 45,164 (0%) | 0% | 136.3 | 606,399 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 12,449 | 12,449 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 3,972 | 11,916 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 3,972 | 42,333 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 142.66 per share. | 16 Feb 2021 | 2,020 | 40,313 (0%) | 0% | 142.7 | 288,173 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 94.38 per share. | 31 Jul 2020 | 15,604 | 44,073 (0%) | 0% | 94.4 | 1,472,706 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 93.30 per share. | 31 Jul 2020 | 9,151 | 59,677 (0%) | 0% | 93.3 | 853,788 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.68 per share. | 31 Jul 2020 | 6,638 | 75,861 (0%) | 0% | 21.7 | 143,912 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 6,638 | 58,362 | - | - | Stock Option (right to buy) | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 92.39 per share. | 31 Jul 2020 | 5,633 | 68,828 (0%) | 0% | 92.4 | 520,433 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.11 per share. | 31 Jul 2020 | 5,312 | 38,761 (0%) | 0% | 95.1 | 505,224 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 91.18 per share. | 31 Jul 2020 | 1,400 | 74,461 (0%) | 0% | 91.2 | 127,652 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 97.42 per share. | 31 Jul 2020 | 400 | 38,361 (0%) | 0% | 97.4 | 38,968 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2020 | 18,750 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.81 per share. | 28 Jul 2020 | 18,750 | 77,969 (0%) | 0% | 94.8 | 1,777,688 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.58 per share. | 28 Jul 2020 | 8,746 | 69,223 (0%) | 0% | 95.6 | 835,943 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 60.60 per share. | 28 Jul 2020 | 351 | 59,219 (0%) | 0% | 60.6 | 21,271 | Common Stock |
| Exact Sciences Corp. | Jeffrey T. Elliott | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 60.60 per share. | 28 Jul 2020 | 110 | 59,109 (0%) | 0% | 60.6 | 6,666 | Common Stock |
| Exagen Inc | Jeffrey T. Elliott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 9,000 | 9,000 | - | - | Stock Option(right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges